Please find enclosed the Annual Report for the Financial Year 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals Ltd has submitted its Annual Report for the financial year 2024-25 to the stock exchange, as required under listing regulations. The filing is a routine compliance disclosure and the full report would contain audited financial statements, directors' report, and other statutory disclosures. The headline itself does not provide any financial figures, segment performance, or auditor observations. Retail investors would need to review the attached annual report for detailed financial performance.
This is a standard regulatory filing and typically does not move the stock price on its own. Shareholders should review the full annual report for key financial metrics, auditor's opinion, and any material developments during the year.